Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00004911What this trial is testingEndoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more Northwestern University
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00002470What this trial is testingFluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid TumorsWho this might be right forGastrointestinal Carcinoid TumorLung Cancer Mid-Atlantic Oncology Program
Testing effectiveness (Phase 2)Study completedNCT00004910What this trial is testingEndoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more Northwestern University
Not applicableUnknownNCT00454376What this trial is testingDisease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more National Cancer Institute (NCI) 408
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00454363What this trial is testingPazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Ended earlyNCT00084461What this trial is testingRomidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00075439What this trial is testingGefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more National Cancer Institute (NCI) 90
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT02259725What this trial is testingRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more University of Southern California 3
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41